دورية
Clinical Outcomes and Toxicity in Older Adults Receiving Chimeric Antigen Receptor T Cell Therapy
العنوان: | Clinical Outcomes and Toxicity in Older Adults Receiving Chimeric Antigen Receptor T Cell Therapy |
---|---|
المؤلفون: | Johnson, P. Connor, Neckermann, Isabel, Sadrzadeh, Hossein, Newcomb, Richard, El-Jawahri, Areej R., Frigault, Matthew J. |
المصدر: | Transplantation and Cellular Therapy; May 2024, Vol. 30 Issue: 5 p490-499, 10p |
مستخلص: | •Age 75+ years was not associated with higher CAR-T toxicity compared to age 65-74.•Age 75+ years was not associated with higher healthcare utilization versus age 65 to 74 years.•We found encouraging rates of overall survival across age categories.•These results support that age alone is not a contraindication for CAR-T. |
قاعدة البيانات: | Supplemental Index |
تدمد: | 26666375 26666367 |
---|---|
DOI: | 10.1016/j.jtct.2024.02.019 |